A study of allogeneic chimeric antigen receptor (CAR) T cells in the treatment of cancer

Trial Profile

A study of allogeneic chimeric antigen receptor (CAR) T cells in the treatment of cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 02 May 2016

At a glance

  • Drugs T lymphocyte cell therapies (Primary)
  • Indications Cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 May 2016 I have added a drug class, as it is there are multiple targets so a specific Thes term is not available. Also multiple trials could be initiated in specific cancer types. Please modify accordingly.
    • 02 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top